Latest news
72 patient multi-indication trial approved to fast track TRP-8803 commercialisation - Tirto.idTirto.id · Tue, 04 Aug 2026 20:39:06 GMTEntropy Neurodynamics Secures Ethics Approval for 72-Patient, Eight-Indication TRP-8803 Basket Study - KalkineKalkine · Tue, 04 Aug 2026 03:54:05 GMTEntropy secures ethics approval for multi-indication trial - The AustralianThe Australian · Tue, 04 Aug 2026 03:31:00 GMTAdlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia - The Manila TimesThe Manila Times · Mon, 03 Aug 2026 11:19:31 GMTCREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases - PR NewswirePR Newswire · Thu, 30 Jul 2026 11:00:00 GMT